Autoantibodies against galectin-2 peptides as biomarkers for the antiphospholipid syndrome

Abstract

Autoantibodies against opsonins of dying and dead cells mediate Fcγ receptor-dependent phagocytosis of autologous apoptotic and necrotic cells and hereby tend to elicit inflammation instead of silent clearance. We analysed sera of patients with chronic autoimmune diseases for the occurrence of IgG autoantibodies recognizing galectins. These pluripotent effectors can also bind to apoptotic or necrotic cells. Patients with antiphospholipid syndrome (APS; n = 104) and systemic lupus erythematosus (SLE; n = 62) were examined, healthy donors (n = 31) served as controls. Selected peptides of galectin (Gal)-2 were employed for peptide-based ELISAs. Levels of anti-Gal-2^PEP-IgG were significantly increased in SLE and APS when compared with controls. In addition, patients with APS showed significantly higher levels of anti-Gal-2^PEP-IgG compared with patients with SLE. Anti-Gal-2^PEP-IgG may, therefore, be considered novel biomarkers for APS.

Keywords

antiphospholipid syndrome autoantibodies lectins systemic lupus erythematosus

Get full access to this article

View all access options for this article.

References

Schulze

Munoz

Franz

. Clearance deficiency–a potential link between infections and autoimmunity. Autoimmun Rev 2008; 8: 5–8.

Munoz

Lauber

Schiller

. The role of defective clearance of apoptotic cells in systemic autoimmunity. Nat Rev Rheumatol 2010; 6: 280–289.

Gabius

Andre

Jimenez-Barbero

. From lectin structure to functional glycomics: principles of the sugar code. Trends Biochem Sci 2011; 36: 298–313.

Kaltner H, Gabius H. A toolbox of lectins for translating the sugar code: the galectin network in phylogenesis and tumors. Histol Histopathol 2012; in press.

Beer

Andre

Kaltner

. Human galectins as sensors for apoptosis/necrosis-associated surface changes of granulocytes and lymphocytes. Cytometry A 2008; 73: 139–147.

Karlsson

Christenson

Matlak

. Galectin-3 functions as an opsonin and enhances the macrophage clearance of apoptotic neutrophils. Glycobiology 2009; 19: 16–20.

Massardo

Metz

Pardo

. Autoantibodies against galectin-8: their specificity, association with lymphopenia in systemic lupus erythematosus and detection in rheumatoid arthritis and acute inflammation. Lupus 2009; 8: 539–546.

Janko C, Franz S, Munoz L, et al. CRP/anti-CRP antibodies assembly on the surfaces of cell remnants switches their phagocytic clearance toward inflammation. Front Immun 2011; 2.

Miyakis

Lockshin

Atsumi

. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295–306.

10.

Hochberg

. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725–1725.

11.

Neimark

Briand

. Development of a fully automated multichannel peptide synthesizer with integrated TFA cleavage capability. Pept Res 1993; 6: 219–228.

12.

Andre

Kaltner

Lensch

. Determination of structural and functional overlap/divergence of five proto-type galectins by analysis of the growth-regulatory interaction with ganglioside GM1 in silico and in vitro on human neuroblastoma cells. Int J Cancer 2005; 114: 46–57.